DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Wang M, Wang Z, Zhi X. et al.
SOX9 enhances sorafenib resistance through upregulating ABCG2 expression in hepatocellular carcinoma.
Biomed Pharmacother 2020;
129: 110315
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.